|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.860 EUR | +0.77% |
|
-4.15% | +25.76% |
| Market Cap | 43.93M 50M 41.01M 37.64M 70.45M 4.79B 72.19M 486M 190M 2.37B 188M 184M 8.19B | P/E 2026 * |
-20x | P/E 2027 * | 195x |
|---|---|---|---|---|---|
| Enterprise Value | 42.43M 48.29M 39.61M 36.35M 68.05M 4.63B 69.72M 470M 184M 2.29B 181M 177M 7.91B | EV / Sales 2026 * |
3.86x | EV / Sales 2027 * | 2.69x |
| Free-Float |
29.17% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.77% | ||
| 1 week | -4.15% | ||
| Current month | +1.29% | ||
| 1 month | +1.29% | ||
| 3 months | +6.22% | ||
| 6 months | +12.29% | ||
| Current year | +25.76% |
| 1 week | 7.3 | 8.4 | |
| 1 month | 7.3 | 8.94 | |
| Current year | 6 | 9.1 | |
| 1 year | 5.5 | 9.1 | |
| 3 years | 2.14 | 9.1 | |
| 5 years | 1.9 | 9.1 | |
| 10 years | 1.9 | 9.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 28/12/2008 | |
Renaut Fritsch
DFI | Director of Finance/CFO | - | 31/05/2022 |
Thibaut Bastien
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 29/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.77% | -4.15% | +3.42% | +222.13% | 50M | ||
| -0.87% | +4.04% | +58.60% | +163.92% | 1,079B | ||
| -0.45% | +3.87% | +57.95% | +52.18% | 640B | ||
| +0.04% | +3.95% | +37.69% | +74.54% | 465B | ||
| -2.54% | +1.29% | +36.36% | +30.82% | 353B | ||
| -1.71% | +0.06% | +34.43% | +40.27% | 301B | ||
| -2.85% | +0.87% | +11.31% | +14.41% | 271B | ||
| -2.16% | +3.70% | +2.20% | -39.18% | 228B | ||
| -1.39% | +5.90% | +27.70% | +64.00% | 209B | ||
| -1.18% | +1.83% | +16.20% | +72.69% | 165B | ||
| Average | -1.65% | +4.35% | +28.59% | +69.58% | 370.97B | |
| Weighted average by Cap. | -2.06% | +4.86% | +41.26% | +77.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 11M 12.52M 10.27M 9.42M 17.64M 1.2B 18.07M 122M 47.62M 593M 47M 45.98M 2.05B | 16M 18.21M 14.93M 13.71M 25.66M 1.74B 26.29M 177M 69.26M 863M 68.36M 66.88M 2.98B |
| Net income | -2.25M -2.56M -2.1M -1.93M -3.61M -245M -3.7M -24.9M -9.74M -121M -9.61M -9.41M -420M | 250K 285K 233K 214K 401K 27.25M 411K 2.77M 1.08M 13.49M 1.07M 1.05M 46.62M |
| Net Debt | -1.5M -1.71M -1.4M -1.28M -2.41M -164M -2.46M -16.6M -6.49M -80.91M -6.41M -6.27M -280M | -900K -1.02M -840K -771K -1.44M -98.11M -1.48M -9.96M -3.9M -48.55M -3.85M -3.76M -168M |
Employees
45
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/07/26 | €7.860 | +0.77% | 507 |
| 29/07/26 | €7.800 | -2.50% | 2,563 |
| 28/07/26 | €8.000 | -1.23% | 295 |
| 27/07/26 | €8.100 | -2.41% | 147 |
| 24/07/26 | €8.300 | +1.22% | 312 |
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
7.800EUR
Average target price
8.200EUR
Spread / Average Target
+5.13%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALSMA Stock
Select your edition
All financial news and data tailored to specific country editions
















